Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals

Yoko Hirabayashi, Kazushige Maki, Kiyoshi Kinoshita, Takahiro Nakazawa, Satoshi Obika, Misaki Naota, Kazuto Watanabe, Mutsumi Suzuki, Teruyo Arato, Aki Fujisaka, Osamu Fueki, Kosuke Ito, Hiroshi Onodera

Open source

DOI
10.1089/nat.2020.0879
Published
2021-03-25
Container
Nucleic Acid Therapeutics
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1089/nat.2020.0879,
  title = {Considerations of the Japanese Research Working Group for the ICH S6 \& Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals},
  author = {Yoko Hirabayashi and Kazushige Maki and Kiyoshi Kinoshita and Takahiro Nakazawa and Satoshi Obika and Misaki Naota and Kazuto Watanabe and Mutsumi Suzuki and Teruyo Arato and Aki Fujisaka and Osamu Fueki and Kosuke Ito and Hiroshi Onodera},
  year = {2021},
  journal = {Nucleic Acid Therapeutics},
  doi = {10.1089/nat.2020.0879},
  url = {https://doi.org/10.1089/nat.2020.0879}
}

RIS

TY  - JOUR
TI  - Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
AU  - Yoko Hirabayashi
AU  - Kazushige Maki
AU  - Kiyoshi Kinoshita
AU  - Takahiro Nakazawa
AU  - Satoshi Obika
AU  - Misaki Naota
AU  - Kazuto Watanabe
AU  - Mutsumi Suzuki
AU  - Teruyo Arato
AU  - Aki Fujisaka
AU  - Osamu Fueki
AU  - Kosuke Ito
AU  - Hiroshi Onodera
PY  - 2021
JO  - Nucleic Acid Therapeutics
DO  - 10.1089/nat.2020.0879
UR  - https://doi.org/10.1089/nat.2020.0879
ER  - 

APA

Hirabayashi, Y., Maki, K., Kinoshita, K., Nakazawa, T., Obika, S., Naota, M., Watanabe, K., Suzuki, M., Arato, T., Fujisaka, A., Fueki, O., Ito, K., & Onodera, H. (2021). Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2020.0879

Source records